USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: PDX PHARMACEUTICALS, LLC
City: LAKE OSWEGO
State: OR
Zip+4: 97035-1401
Woman-Owned: Yes
Minority-Owned: Yes
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,000.00 1
STTR Phase I $299,741.00 1

Award List:

Iron functionalized silica as oral phosphate binder to treat hyperphosphatemia

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: OREGON HEALTH AND SCIENCE UNIVERSITY
Principal Investigator: Wassana Yantasee – 503-418-9306
Award Amount: $299,741.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Hyperphosphatemia is universal to end stage chronic kidney disease patients and a majority of dialysis patients totaling of 400,000 in the US and 2 million worldwide. Current oral phosphate binders to treat hyperphosphatemia still have many drawbacks, including a… More

PDX Pharmaceuticals

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: David Castro – 503-418-9306
Award Amount: $200,000.00
Abstract:
Over one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted therapies, including Herceptin and lapatinib, account for 55% of the breast cancer therapy market in… More